vs
KEMPER Corp（KMPR）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
KEMPER Corp的季度营收约是Royalty Pharma plc的1.8倍（$1.1B vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs -0.7%，领先35.1%），Royalty Pharma plc同比增速更快（4.8% vs -4.7%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -0.5%）
坎伯公司（Kemper Corporation）是总部位于美国伊利诺伊州芝加哥的保险服务商，总资产近130亿美元，旗下品牌矩阵为个人、家庭及企业客户提供多元保险产品服务。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
KMPR vs RPRX — 直观对比
营收规模更大
KMPR
是对方的1.8倍
$622.0M
营收增速更快
RPRX
高出9.4%
-4.7%
净利率更高
RPRX
高出35.1%
-0.7%
两年增速更快
RPRX
近两年复合增速
-0.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $622.0M |
| 净利润 | $-8.0M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | — | 62.4% |
| 净利率 | -0.7% | 34.4% |
| 营收同比 | -4.7% | 4.8% |
| 净利润同比 | -108.2% | 2.9% |
| 每股收益（稀释后） | $-0.03 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KMPRRPRX
| Q4 25 | $1.1B | $622.0M | ||
| Q3 25 | $1.2B | $609.3M | ||
| Q2 25 | $1.2B | $578.7M | ||
| Q1 25 | $1.2B | $568.2M | ||
| Q4 24 | $1.2B | $593.6M | ||
| Q3 24 | $1.2B | $564.7M | ||
| Q2 24 | $1.1B | $537.3M | ||
| Q1 24 | $1.1B | $568.0M |
净利润KMPRRPRX
| Q4 25 | $-8.0M | $214.2M | ||
| Q3 25 | $-21.0M | $288.2M | ||
| Q2 25 | $72.6M | $30.2M | ||
| Q1 25 | $99.7M | $238.3M | ||
| Q4 24 | $97.4M | $208.2M | ||
| Q3 24 | $73.7M | $544.0M | ||
| Q2 24 | $75.4M | $102.0M | ||
| Q1 24 | $71.3M | $4.8M |
营业利润率KMPRRPRX
| Q4 25 | — | 62.4% | ||
| Q3 25 | — | 70.1% | ||
| Q2 25 | — | 36.3% | ||
| Q1 25 | — | 94.0% | ||
| Q4 24 | — | 60.9% | ||
| Q3 24 | 11.2% | — | ||
| Q2 24 | 10.1% | 50.2% | ||
| Q1 24 | 7.6% | -13.0% |
净利率KMPRRPRX
| Q4 25 | -0.7% | 34.4% | ||
| Q3 25 | -1.7% | 47.3% | ||
| Q2 25 | 5.9% | 5.2% | ||
| Q1 25 | 8.4% | 41.9% | ||
| Q4 24 | 8.2% | 35.1% | ||
| Q3 24 | 6.3% | 96.3% | ||
| Q2 24 | 6.7% | 19.0% | ||
| Q1 24 | 6.2% | 0.8% |
每股收益（稀释后）KMPRRPRX
| Q4 25 | $-0.03 | $0.49 | ||
| Q3 25 | $-0.34 | $0.67 | ||
| Q2 25 | $1.12 | $0.07 | ||
| Q1 25 | $1.54 | $0.55 | ||
| Q4 24 | $1.51 | $0.46 | ||
| Q3 24 | $1.14 | $1.21 | ||
| Q2 24 | $1.16 | $0.23 | ||
| Q1 24 | $1.10 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $618.7M |
| 总债务越低越好 | $943.5M | $9.0B |
| 股东权益账面价值 | $2.7B | $9.7B |
| 总资产 | $12.5B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.35× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资KMPRRPRX
| Q4 25 | — | $618.7M | ||
| Q3 25 | $371.2M | $938.9M | ||
| Q2 25 | $407.6M | $631.9M | ||
| Q1 25 | $545.3M | $1.1B | ||
| Q4 24 | $1.0B | $929.0M | ||
| Q3 24 | $696.9M | $950.1M | ||
| Q2 24 | $539.1M | $1.8B | ||
| Q1 24 | $520.7M | $843.0M |
总债务KMPRRPRX
| Q4 25 | $943.5M | $9.0B | ||
| Q3 25 | $943.1M | $8.9B | ||
| Q2 25 | $942.6M | $8.0B | ||
| Q1 25 | $942.1M | $7.6B | ||
| Q4 24 | $1.4B | $7.6B | ||
| Q3 24 | $1.4B | $7.6B | ||
| Q2 24 | $1.4B | $7.6B | ||
| Q1 24 | $1.4B | $6.1B |
股东权益KMPRRPRX
| Q4 25 | $2.7B | $9.7B | ||
| Q3 25 | $2.7B | $9.6B | ||
| Q2 25 | $370.0M | $9.5B | ||
| Q1 25 | $366.0M | $9.8B | ||
| Q4 24 | $2.8B | $10.3B | ||
| Q3 24 | $2.8B | $10.3B | ||
| Q2 24 | $358.0M | $9.8B | ||
| Q1 24 | $2.6B | $9.9B |
总资产KMPRRPRX
| Q4 25 | $12.5B | $19.6B | ||
| Q3 25 | $12.4B | $19.3B | ||
| Q2 25 | $12.6B | $18.3B | ||
| Q1 25 | $12.5B | $17.6B | ||
| Q4 24 | $12.6B | $18.2B | ||
| Q3 24 | $12.6B | $18.0B | ||
| Q2 24 | $12.6B | $17.7B | ||
| Q1 24 | $12.6B | $16.1B |
负债/权益比KMPRRPRX
| Q4 25 | 0.35× | 0.92× | ||
| Q3 25 | 0.35× | 0.93× | ||
| Q2 25 | 2.55× | 0.84× | ||
| Q1 25 | 2.57× | 0.78× | ||
| Q4 24 | 0.50× | 0.74× | ||
| Q3 24 | 0.50× | 0.74× | ||
| Q2 24 | 3.88× | 0.78× | ||
| Q1 24 | 0.54× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $175.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $166.2M | — |
| 自由现金流率自由现金流/营收 | 14.7% | — |
| 资本支出强度资本支出/营收 | 0.8% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | $553.9M | — |
8季度趋势，按日历期对齐
经营现金流KMPRRPRX
| Q4 25 | $175.0M | $827.1M | ||
| Q3 25 | $139.9M | $702.6M | ||
| Q2 25 | $89.6M | $364.0M | ||
| Q1 25 | $180.0M | $596.1M | ||
| Q4 24 | $175.1M | $742.5M | ||
| Q3 24 | $141.9M | $703.6M | ||
| Q2 24 | $22.9M | $658.2M | ||
| Q1 24 | $43.0M | $664.6M |
自由现金流KMPRRPRX
| Q4 25 | $166.2M | — | ||
| Q3 25 | $133.4M | — | ||
| Q2 25 | $82.0M | — | ||
| Q1 25 | $172.3M | — | ||
| Q4 24 | $165.4M | — | ||
| Q3 24 | $131.4M | — | ||
| Q2 24 | $5.2M | — | ||
| Q1 24 | $27.7M | — |
自由现金流率KMPRRPRX
| Q4 25 | 14.7% | — | ||
| Q3 25 | 10.8% | — | ||
| Q2 25 | 6.7% | — | ||
| Q1 25 | 14.4% | — | ||
| Q4 24 | 13.9% | — | ||
| Q3 24 | 11.1% | — | ||
| Q2 24 | 0.5% | — | ||
| Q1 24 | 2.4% | — |
资本支出强度KMPRRPRX
| Q4 25 | 0.8% | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.8% | — | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | 1.6% | — | ||
| Q1 24 | 1.3% | — |
现金转化率KMPRRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | 1.23× | 12.06× | ||
| Q1 25 | 1.81× | 2.50× | ||
| Q4 24 | 1.80× | 3.57× | ||
| Q3 24 | 1.93× | 1.29× | ||
| Q2 24 | 0.30× | 6.45× | ||
| Q1 24 | 0.60× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KMPR
| Specialty Property Casualty Insurance Segment | $995.1M | 88% |
| Life Insurance Segment1 | $140.7M | 12% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
